CD133 and CD44 antigens happen to be the most widely studied CSCs markers in CRC and combination of these markers could be helpful in identifying CSCs.18 In this study, we investigated CRC patients for cellular expression of CD133 and CD44 antigen using flow cytometry in normal, tumour and distal tissues obtained post surgery. The gene discussed is PROM1; the disease is colorectal carcinoma.